Fixation of the Orogastric Tube: Which Method for the Newborn ?

NCT ID: NCT04233333

Last Updated: 2021-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-12

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is recommended to respect the perioral zone by fixing the feeding tube only on the newborn's cheek, in order to promote oral acquisition and avoid repeated dislodgment of probes (HAS). This rule is easily applicable for nasogastric tubes. The difficulty is found for orogastric tubes. The "mustache" is usually used to fix it, but this interferes with the perioral zone and must be changed more often than necessary.

To achieve a more sustainable orogastric tube's fixation to the cheek, a German team directed by W. Krämer developed and tested an orogastric tube's fixing technique that was subsequently approved and used.

Using this German method, a randomized, monocentric superiority study, including 30 newborns and premature babies requiring an orogastric tube, will compared german probe's fixation method to the mustache.

The aim of the study is to ensure a more effective orogastric tube's fixation to reduce the number of fixation changes, probe placements and negative oral stimulations in newborns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enteral Feeding Gastric Emptying

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mustache fixation

Group Type ACTIVE_COMPARATOR

method of fixation of the orogastric tube

Intervention Type DEVICE

Methods of fixation of the orogastric tube will be randomized

W.K fixation

Group Type EXPERIMENTAL

method of fixation of the orogastric tube

Intervention Type DEVICE

Methods of fixation of the orogastric tube will be randomized

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

method of fixation of the orogastric tube

Methods of fixation of the orogastric tube will be randomized

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborns admitted to neonatal intensive care unit
* Express consent of the holders of parental authority
* Orogastric tube indication (enteral feeding, digestive aspiration)

Exclusion Criteria

* Newborns over 2 months of age corrected
* Indication of nasogastric tube
* Port of gastrostomy
* Pathology resulting in hypersalivation or hyper sweating
* Swallowing disorder
* Genetic disease
* Severe neurological impairment
* Cleft lip and / or palate
* Other malformation in the oral sphere or perioral area
* Sedation with morphine analgesics
* Anticonvulsant treatment
* Palliative care
Maximum Eligible Age

2 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire de la Réunion

Saint-Pierre, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lucie AUZANNEAU

Role: CONTACT

(0)262 35 99 49 ext. +262

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lucie AUZANNEAU

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017/CHU/08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.